In rats, cardiac HSP20 is increased with endurance exercise (70–75% of VO2max for 6 weeks), and HSP20 phosphorylation has been identified as a therapeutic target for heart disease (Burniston, 2009) (Table 2). The gene discussed is HSPB6; the disease is heart disorder.